SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11464981
Source:
http://linkedlifedata.com/resource/pubmed/id/11464981
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0018956
,
umls-concept:C0035820
,
umls-concept:C0036525
,
umls-concept:C0087111
,
umls-concept:C0855069
,
umls-concept:C1328050
,
umls-concept:C1522484
pubmed:issue
5
pubmed:dateCreated
2001-7-23
pubmed:abstractText
This review summarizes the published data on the use of high-dose chemotherapy and hematopoietic stem cell rescue (HSCR) in the treatment of recurrent or metastatic rhabdomyosarcoma (RMS).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11464981-11464979
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9505928
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Thiotepa
pubmed:status
MEDLINE
pubmed:issn
1077-4114
pubmed:author
pubmed-author:BakerK SKS
,
pubmed-author:BreitfeldP PPP
,
pubmed-author:CristW MWM
,
pubmed-author:HawkinsDD
,
pubmed-author:WeigelB JBJ
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
272-6
pubmed:dateRevised
2011-10-6
pubmed:meshHeading
pubmed-meshheading:11464981-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:11464981-Bone Marrow Diseases
,
pubmed-meshheading:11464981-Child
,
pubmed-meshheading:11464981-Child, Preschool
,
pubmed-meshheading:11464981-Clinical Trials as Topic
,
pubmed-meshheading:11464981-Combined Modality Therapy
,
pubmed-meshheading:11464981-Cyclophosphamide
,
pubmed-meshheading:11464981-Disease-Free Survival
,
pubmed-meshheading:11464981-Hematopoietic Stem Cell Transplantation
,
pubmed-meshheading:11464981-Humans
,
pubmed-meshheading:11464981-Infant
,
pubmed-meshheading:11464981-Life Tables
,
pubmed-meshheading:11464981-MEDLINE
,
pubmed-meshheading:11464981-Neoplasm Metastasis
,
pubmed-meshheading:11464981-Neoplasm Recurrence, Local
,
pubmed-meshheading:11464981-Neoplasm Staging
,
pubmed-meshheading:11464981-Prospective Studies
,
pubmed-meshheading:11464981-Remission Induction
,
pubmed-meshheading:11464981-Rhabdomyosarcoma
,
pubmed-meshheading:11464981-Risk
,
pubmed-meshheading:11464981-Soft Tissue Neoplasms
,
pubmed-meshheading:11464981-Survival Analysis
,
pubmed-meshheading:11464981-Thiotepa
,
pubmed-meshheading:11464981-Transplantation Conditioning
,
pubmed-meshheading:11464981-Treatment Outcome
,
pubmed-meshheading:11464981-Whole-Body Irradiation
pubmed:articleTitle
Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma.
pubmed:affiliation
Department of Pediatrics, University of Minnesota, Minneapolis 55455, USA. weige007@tc.umn.edu
pubmed:publicationType
Journal Article
,
Meta-Analysis